In Task 2, which aimed at distinguishing between HER2-positive and HER2-low cancers, LASSO analysis selected 23 radiomic features, comprising 12 from within the tumor and 11 from the peritumoral zone, as illustrated in Figures S2B. This evidence concerns the gene ERBB2 and neoplasm.